TSWM
EVFM

Tyler-Stone Wealth Management’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

Tyler-Stone Wealth Management’s Portfolio EVFM Stock Details EVFM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-15
Closed – – 932
2022
Q1 		$0 Buy
+15
New +$94 ﹤0.01% 978

Other funds holding EVFM

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Tyler-Stone Wealth Management's EVFM Position: Q2 2022 in Review

Tyler-Stone Wealth Management sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q2 2022, closing a stake of 15 shares.

Tyler-Stone Wealth Management first reported a position in EVFM in Q1 2022 and held it in 1 quarter. The position peaked at $0 in Q1 2022. 44 funds tracked by Wall St. Rank hold EVFM as of Q2 2022.

  • Tyler-Stone Wealth Management reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Tyler-Stone Wealth Management sold 15 Evofem Biosciences, Inc. Common Stock shares in Q2 2022.
  • Tyler-Stone Wealth Management first reported a position in Evofem Biosciences, Inc. Common Stock in Q1 2022 and held it in 1 quarter.
  • Tyler-Stone Wealth Management's Evofem Biosciences, Inc. Common Stock position peaked at $0 in Q1 2022.
  • 44 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q2 2022.

Based on Tyler-Stone Wealth Management's 13F filing for Q2 2022, filed 11 Aug 2022.